A Purdue University mechanical engineer and his international collaborators have developed a patent-pending method and algorithm to predict the recurrence of prostate cancer in patients treated by radiation therapy.
Oct 9, 2023
0
5
Patients with X-linked severe combined immunodeficiency disorder (SCID-X1), sometimes called "bubble boy disease," are born with a defective gene that prevents them from producing immune cells. Gene therapy from St. Jude ...
Oct 6, 2023
0
26
A recent study found new ways to identify mismatches between donors and recipients in kidney transplantation.
Oct 6, 2023
0
3
Alberta men with elevated prostate-specific antigen (PSA) levels can now take a new blood test to determine their risk for clinically significant prostate cancer and potentially avoid an unnecessary biopsy.
Oct 6, 2023
0
30
A research group has created a new model to calculate the probability of the occurrence of localized clusters caused by novel coronavirus infections. Led by Shingo Iwami at Nagoya University with collaborators in the United ...
Oct 4, 2023
0
6
A new study has demonstrated rapid and sensitive on-site detection of SARS-CoV-2 RNA from environmental surfaces using a portable laboratory device. The study was published in Microbiology Spectrum.
Oct 4, 2023
0
26
Scientists from Tokyo Metropolitan University have realized a new polymer that can effectively transport plasmid DNA into T-cells during chimeric antigen receptor (CAR) T-cell therapy, a key treatment for blood cancer. Importantly, ...
Oct 2, 2023
0
12
At-home COVID-19 tests allow you to collect your sample and detect active COVID-19 infections.
Sep 20, 2023
0
2
You feel unwell, and visit your doctor. They ask some questions and take some blood for testing; a few days later they call to say you have been diagnosed with a disease.
Sep 19, 2023
0
15
When Michel Sadelain began his decades-long quest to genetically modify immune cells to fight cancer, his peers dismissed his ideas as absurd and even his mother grew concerned for his career.
Sep 14, 2023
0
24
